{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:32:04Z","timestamp":1791509524965,"version":"4.3.4"},"reference-count":46,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2013,2,26]],"date-time":"2013-02-26T00:00:00Z","timestamp":1361836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2013,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>For several decades, metformin has been used as an oral hypoglycaemic agent, where it is the first line of treatment in overweight and obese type 2 diabetic patients. This is because it decreases the hepatic glucose output and acts as an insulin sensitizer by increasing the glucose utilization by muscles and adipocytes. As a result of the improvement in glycaemic control, serum insulin concentrations decline slightly, thus improving hyperinsulinaemia and its signs. In addition, it has been shown that metformin has platelet anti\u2010aggregating and antioxidant effects. These pharmacological properties have allowed metformin to be effective in non\u2010diabetic situations including cutaneous conditions. This is an evidence\u2010based review on the use of metformin in the treatment of skin disorders such as hirsutism, acne, hidradenitis suppurativa, acanthosis nigricans, psoriasis, skin cancer, among others. In addition, cutaneous side\u2010effects such as leukocytoclastic vasculitis, bullous pemphigoid, psoriasiform drug eruption, lichen planus and acute alopecia have been associated with metformin use and are discussed in the article.<\/jats:p>","DOI":"10.1111\/jdv.12116","type":"journal-article","created":{"date-parts":[[2013,2,26]],"date-time":"2013-02-26T04:08:46Z","timestamp":1361851726000},"page":"1329-1335","source":"Crossref","is-referenced-by-count":56,"title":["Metformin in dermatology: an overview"],"prefix":"10.1111","volume":"27","author":[{"given":"D.","family":"Badr","sequence":"first","affiliation":[{"name":"Department of Dermatology American University of Beirut Medical Center Beirut Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kurban","sequence":"additional","affiliation":[{"name":"Department of Dermatology American University of Beirut Medical Center Beirut Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Abbas","sequence":"additional","affiliation":[{"name":"Department of Dermatology American University of Beirut Medical Center Beirut Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,2,26]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-137-1-200207020-00009"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1042\/CS20110386"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03345423"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.387"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.3109\/09537104.2012.674165"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1262-3636(03)72787-6"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012512"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-131-4-199908170-00008"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.genm.2010.04.002"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-8-41"},{"key":"e_1_2_5_12_1","first-page":"25","article-title":"Neuroendocrine and endocrine dysfunction in the hyperinsulinemic PCOS patient: the role of metformin","volume":"37","author":"Weickert MO","year":"2012","journal-title":"Minerva Endocrinol"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030424"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1470217"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-0555"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1159\/000187718"},{"key":"e_1_2_5_17_1","first-page":"4","article-title":"Physiopathology of acne vulgaris: recent data, new understanding of the treatments","volume":"14","author":"Pawin H","year":"2004","journal-title":"Eur J Dermatol"},{"key":"e_1_2_5_18_1","first-page":"569","article-title":"Everything old is new again: spironolactone and metformin in the treatment of acne","volume":"9","author":"Bergstrom KG","year":"2010","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1671"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.4161\/derm.2.1.12490"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2008.03121.x"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468\u20103083.2012.04668.x"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200405030-00008"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-07-0857"},{"key":"e_1_2_5_25_1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1042\/bj3480083","article-title":"Chronic insulin effects on insulin signalling and GLUT4 endocytosis are reversed by metformin","volume":"348","author":"Pryor PR","year":"2000","journal-title":"Biochem J"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1210\/en.2005-1433"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1470.2002.00013.x"},{"key":"e_1_2_5_28_1","first-page":"677","article-title":"Improvement of acanthosis nigricans on isotretinoinand metformin","volume":"2","author":"Walling HW","year":"2003","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_5_29_1","first-page":"884","article-title":"Comparison of metformin versus rosiglitazone in patients with Acanthosis nigricans: a pilot study","volume":"5","author":"Bellot\u2010Rojas P","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03345776"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.11.023"},{"key":"e_1_2_5_32_1","first-page":"412","article-title":"Psoriasis and phenformin hydrochloride: a report on 2 cases","volume":"71","author":"Babad F","year":"1974","journal-title":"J Med Soc N J"},{"key":"e_1_2_5_33_1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5070\/D37CF866X9","article-title":"Psoriasiform drug eruption associated with metformin hydrochloride: a case report","volume":"9","author":"Koca R","year":"2003","journal-title":"Dermatol Online J"},{"key":"e_1_2_5_34_1","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5154.62757"},{"key":"e_1_2_5_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2011.86"},{"key":"e_1_2_5_36_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-11-0280"},{"key":"e_1_2_5_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-1097.2012.01165.x"},{"key":"e_1_2_5_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10517-011-1331-y"},{"key":"e_1_2_5_39_1","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-11-0502"},{"key":"e_1_2_5_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00105-009-1847-5"},{"key":"e_1_2_5_41_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI13505"},{"key":"e_1_2_5_42_1","doi-asserted-by":"publisher","DOI":"10.3132\/dvdr.2008.027"},{"key":"e_1_2_5_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.04062.x"},{"key":"e_1_2_5_44_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.293.6545.483"},{"key":"e_1_2_5_45_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1H155"},{"key":"e_1_2_5_46_1","doi-asserted-by":"publisher","DOI":"10.2165\/11593230-000000000-00000"},{"key":"e_1_2_5_47_1","doi-asserted-by":"publisher","DOI":"10.1159\/000246152"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjdv.12116","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjdv.12116","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.12116","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T00:13:13Z","timestamp":1696205593000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.12116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,26]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["10.1111\/jdv.12116"],"URL":"https:\/\/doi.org\/10.1111\/jdv.12116","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718095220.793482996","asserted-by":"object"}]},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,26]]}}}